ArticleFrontiers in neuroscience2024

Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment.

Karthik Ashok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.